Vigil Neuroscience Q2 EPS $(0.56) Misses $(0.42) Estimate

Vigil Neuroscience (NASDAQ: VIGL) reported quarterly losses of $(0.56) per share which missed the analyst consensus estimate of $(0.42) by 32.08 percent. This is a 7.69 percent decrease over losses of $(0.52) per share from the same period last year.